Anfarma
ActiveSummary
Anfarma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €333,952 and a net result of €45,663. Equity is growing by about 5.3% per year across the filed financial years. Its solvency ranks better than 92% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
26-06
Gazette deed
Resignations: VERGULT An, VAN HOYWEGHEN Nicole and VAN ROBBROECK NikolaasAppointment: VERGULT An (enige niet statutair bestuurder) · Amendment of the articles · Capital conversion10 facts ▸
- Amendment of the articles (2 times)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “vormen en meerderheden van statutenwijziging, opheffing statutair onbeschikbare eigen vermogensrekening inclusief eventuele uitgiftepremies” (deed in Dutch)
- Other provision, “coördinatie statuten, coördinatie opmaken en ondertekenen overeenkomstig vorig besluit en neerlegging in vennootschapsdossier verzorgen” (deed in Dutch)
- Director resignation, VERGULT An (manager)
- Director resignation, VAN HOYWEGHEN Nicole (manager)
- Director resignation, VAN ROBBROECK Nikolaas (manager)
- Director appointment, VERGULT An (enige niet statutair bestuurder)
- Other provision, “uitoefening mandaat, kwijting ontslagnemende zaakvoerders” (deed in Dutch)
- Registered office clause, “adreswijziging bevestigd, 2018 Antwerpen,Schulstraat 1” (deed in Dutch)
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.